Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Jun;70(824):418–427. doi: 10.1136/pgmj.70.824.418

New concepts in diabetes mellitus. I: Treatment, pregnancy and aetiology.

R Taylor 1, M Vanderpump 1
PMCID: PMC2397720  PMID: 8029161

Full text

PDF
418

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahern J. A., Gatcomb P. M., Held N. A., Petit W. A., Jr, Tamborlane W. V. Exaggerated hyperglycemia after a pizza meal in well-controlled diabetes. Diabetes Care. 1993 Apr;16(4):578–580. doi: 10.2337/diacare.16.4.578. [DOI] [PubMed] [Google Scholar]
  2. Araki E., Sun X. J., Haag B. L., 3rd, Chuang L. M., Zhang Y., Yang-Feng T. L., White M. F., Kahn C. R. Human skeletal muscle insulin receptor substrate-1. Characterization of the cDNA, gene, and chromosomal localization. Diabetes. 1993 Jul;42(7):1041–1054. doi: 10.2337/diab.42.7.1041. [DOI] [PubMed] [Google Scholar]
  3. Barker D. J., Hales C. N., Fall C. H., Osmond C., Phipps K., Clark P. M. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993 Jan;36(1):62–67. doi: 10.1007/BF00399095. [DOI] [PubMed] [Google Scholar]
  4. Bingley P. J., Bonifacio E., Shattock M., Gillmor H. A., Sawtell P. A., Dunger D. B., Scott R. D., Bottazzo G. F., Gale E. A. Can islet cell antibodies predict IDDM in the general population? Diabetes Care. 1993 Jan;16(1):45–50. doi: 10.2337/diacare.16.1.45. [DOI] [PubMed] [Google Scholar]
  5. Boden G., Chen X., Desantis R., White J., Mozzoli M. Effects of ethanol on carbohydrate metabolism in the elderly. Diabetes. 1993 Jan;42(1):28–34. [PubMed] [Google Scholar]
  6. Chantelau E., Reuter M., Schotes S., Starke A. A. Severe lipoatrophy with human insulin: successfully treated by CSII. Diabet Med. 1993 Jul;10(6):580–581. doi: 10.1111/j.1464-5491.1993.tb00126.x. [DOI] [PubMed] [Google Scholar]
  7. Close E. J., Wiles P. G., Lockton J. A., Walmsley D., Oldham J., Wales J. K. The degree of day-to-day variation in food intake in diabetic patients. Diabet Med. 1993 Jul;10(6):514–520. doi: 10.1111/j.1464-5491.1993.tb00112.x. [DOI] [PubMed] [Google Scholar]
  8. Cook J. T., Levy J. C., Page R. C., Shaw J. A., Hattersley A. T., Turner R. C. Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. BMJ. 1993 Jan 30;306(6873):302–306. doi: 10.1136/bmj.306.6873.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cook J. T., Page R. C., Levy J. C., Hammersley M. S., Walravens E. K., Turner R. C. Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function. Diabet Med. 1993 May;10(4):321–326. doi: 10.1111/j.1464-5491.1993.tb00072.x. [DOI] [PubMed] [Google Scholar]
  10. Dahlquist G., Savilahti E., Landin-Olsson M. An increased level of antibodies to beta-lactoglobulin is a risk determinant for early-onset type 1 (insulin-dependent) diabetes mellitus independent of islet cell antibodies and early introduction of cow's milk. Diabetologia. 1992 Oct;35(10):980–984. doi: 10.1007/BF00401429. [DOI] [PubMed] [Google Scholar]
  11. Davies M. J., Metcalfe J., Gray I. P., Day J. L., Hales C. N. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus. Diabet Med. 1993 May;10(4):305–312. doi: 10.1111/j.1464-5491.1993.tb00070.x. [DOI] [PubMed] [Google Scholar]
  12. Davies M. J., Rayman G., Gray I. P., Day J. L., Hales C. N. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med. 1993 May;10(4):313–320. doi: 10.1111/j.1464-5491.1993.tb00071.x. [DOI] [PubMed] [Google Scholar]
  13. Deschamps I., Boitard C., Hors J., Busson M., Marcelli-Barge A., Mogenet A., Robert J. J. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study. Diabetologia. 1992 Oct;35(10):951–957. doi: 10.1007/BF00401424. [DOI] [PubMed] [Google Scholar]
  14. Fulcher G. R., Walker M., Farrer M., Johnson A. S., Alberti K. G. Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate. Metabolism. 1993 Mar;42(3):308–314. doi: 10.1016/0026-0495(93)90079-4. [DOI] [PubMed] [Google Scholar]
  15. Godsland I. F., Gangar K., Walton C., Cust M. P., Whitehead M. I., Wynn V., Stevenson J. C. Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism. 1993 Jul;42(7):846–853. doi: 10.1016/0026-0495(93)90058-v. [DOI] [PubMed] [Google Scholar]
  16. Gottsäter A., Landin-Olsson M., Fernlund P., Lernmark A., Sundkvist G. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care. 1993 Jun;16(6):902–910. doi: 10.2337/diacare.16.6.902. [DOI] [PubMed] [Google Scholar]
  17. Green A., Gale E. A., Patterson C. C. Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. Lancet. 1992 Apr 11;339(8798):905–909. doi: 10.1016/0140-6736(92)90938-y. [DOI] [PubMed] [Google Scholar]
  18. Gulli G., Ferrannini E., Stern M., Haffner S., DeFronzo R. A. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes. 1992 Dec;41(12):1575–1586. doi: 10.2337/diab.41.12.1575. [DOI] [PubMed] [Google Scholar]
  19. Guthrie R., Hellman R., Kilo C., Hiar C. E., Crowley L. E., Childs B., Fisher R., Pinson M. B., Suttner A., Vittori C. A multisite physician's office laboratory evaluation of an immunological method for the measurement of HbA1c. Diabetes Care. 1992 Nov;15(11):1494–1498. doi: 10.2337/diacare.15.11.1494. [DOI] [PubMed] [Google Scholar]
  20. Heinemann L., Heise T., Jorgensen L. N., Starke A. A. Action profile of the rapid acting insulin analogue: human insulin B28Asp. Diabet Med. 1993 Jul;10(6):535–539. doi: 10.1111/j.1464-5491.1993.tb00116.x. [DOI] [PubMed] [Google Scholar]
  21. Henriksen J. E., Djurhuus M. S., Vaag A., Thye-Rønn P., Knudsen D., Hother-Nielsen O., Beck-Nielsen H. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen. Diabetologia. 1993 Aug;36(8):752–758. doi: 10.1007/BF00401147. [DOI] [PubMed] [Google Scholar]
  22. Henry R. R., Gumbiner B., Ditzler T., Wallace P., Lyon R., Glauber H. S. Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial. Diabetes Care. 1993 Jan;16(1):21–31. doi: 10.2337/diacare.16.1.21. [DOI] [PubMed] [Google Scholar]
  23. Hepburn D. A., MacLeod K. M., Pell A. C., Scougal I. J., Frier B. M. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med. 1993 Apr;10(3):231–237. doi: 10.1111/j.1464-5491.1993.tb00050.x. [DOI] [PubMed] [Google Scholar]
  24. Hotta N., Kakuta H., Sano T., Matsumae H., Yamada H., Kitazawa S., Sakamoto N. Long-term effect of acarbose on glycaemic control in non-insulin-dependent diabetes mellitus: a placebo-controlled double-blind study. Diabet Med. 1993 Mar;10(2):134–138. doi: 10.1111/j.1464-5491.1993.tb00030.x. [DOI] [PubMed] [Google Scholar]
  25. Jenner M., Bradish G., Stiller C., Atkison P. Cyclosporin A treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus. London Diabetes Study Group. Diabetologia. 1992 Sep;35(9):884–888. doi: 10.1007/BF00399937. [DOI] [PubMed] [Google Scholar]
  26. Johnson A. B., Argyraki M., Thow J. C., Cooper B. G., Fulcher G., Taylor R. Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man. Clin Sci (Lond) 1992 Feb;82(2):219–226. doi: 10.1042/cs0820219. [DOI] [PubMed] [Google Scholar]
  27. Johnson A. B., Webster J. M., Sum C. F., Heseltine L., Argyraki M., Cooper B. G., Taylor R. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism. 1993 Sep;42(9):1217–1222. doi: 10.1016/0026-0495(93)90284-u. [DOI] [PubMed] [Google Scholar]
  28. Koivisto V. A., Leirisalo-Repo M., Ebeling P., Tuominen J. A., Knip M., Turunen U., Mandrup-Poulsen T., Pelkonen R. Seven years of remission in a type I diabetic patient. Diabetes Care. 1993 Jul;16(7):990–995. doi: 10.2337/diacare.16.7.990. [DOI] [PubMed] [Google Scholar]
  29. Konje J. C., Otolorin E. O., Ladipo O. A. The effect of continuous subdermal levonorgestrel (Norplant) on carbohydrate metabolism. Am J Obstet Gynecol. 1992 Jan;166(1 Pt 1):15–19. doi: 10.1016/0002-9378(92)91819-v. [DOI] [PubMed] [Google Scholar]
  30. Kostraba J. N., Cruickshanks K. J., Lawler-Heavner J., Jobim L. F., Rewers M. J., Gay E. C., Chase H. P., Klingensmith G., Hamman R. F. Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes. 1993 Feb;42(2):288–295. [PubMed] [Google Scholar]
  31. Kriska A. M., LaPorte R. E., Pettitt D. J., Charles M. A., Nelson R. G., Kuller L. H., Bennett P. H., Knowler W. C. The association of physical activity with obesity, fat distribution and glucose intolerance in Pima Indians. Diabetologia. 1993 Sep;36(9):863–869. doi: 10.1007/BF00400363. [DOI] [PubMed] [Google Scholar]
  32. Laakso M., Edelman S. V., Brechtel G., Baron A. D. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 1992 Sep;41(9):1076–1083. doi: 10.2337/diab.41.9.1076. [DOI] [PubMed] [Google Scholar]
  33. Mortensen H. B., Villumsen J., Vølund A., Petersen K. E., Nerup J. Relationship between insulin injection regimen and metabolic control in young Danish type 1 diabetic patients. The Danish Study Group of Diabetes in Childhood. Diabet Med. 1992 Nov;9(9):834–839. doi: 10.1111/j.1464-5491.1992.tb01902.x. [DOI] [PubMed] [Google Scholar]
  34. Myers M. G., Jr, White M. F. The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains. Diabetes. 1993 May;42(5):643–650. doi: 10.2337/diab.42.5.643. [DOI] [PubMed] [Google Scholar]
  35. Nabarro J. D. Oral hypoglycaemic agents: the first thirty years. J R Coll Physicians Lond. 1992 Jan;26(1):50–55. [PMC free article] [PubMed] [Google Scholar]
  36. Nuttall F. Q. Dietary fiber in the management of diabetes. Diabetes. 1993 Apr;42(4):503–508. doi: 10.2337/diab.42.4.503. [DOI] [PubMed] [Google Scholar]
  37. Perry I. J., Wannamethee S. G., Walker M. K., Shaper A. G. Sporting activity and hyperglycemia in middle-aged men. Diabetes Care. 1993 Apr;16(4):581–583. doi: 10.2337/diacare.16.4.581. [DOI] [PubMed] [Google Scholar]
  38. Phipps K., Barker D. J., Hales C. N., Fall C. H., Osmond C., Clark P. M. Fetal growth and impaired glucose tolerance in men and women. Diabetologia. 1993 Mar;36(3):225–228. doi: 10.1007/BF00399954. [DOI] [PubMed] [Google Scholar]
  39. Pociot F., Reimers J. I., Andersen H. U. Nicotinamide--biological actions and therapeutic potential in diabetes prevention. IDIG Workshop, Copenhagen, Denmark, 4-5 December 1992. Diabetologia. 1993 Jun;36(6):574–576. doi: 10.1007/BF02743277. [DOI] [PubMed] [Google Scholar]
  40. Puhakainen I., Yki-Järvinen H. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes. 1993 Dec;42(12):1694–1699. doi: 10.2337/diab.42.12.1694. [DOI] [PubMed] [Google Scholar]
  41. Randeree H. A., Omar M. A., Motala A. A., Seedat M. A. Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. Diabetes Care. 1992 Oct;15(10):1258–1263. doi: 10.2337/diacare.15.10.1258. [DOI] [PubMed] [Google Scholar]
  42. Redmon J. B., Pyzdrowski K. L., Robertson R. P. No effect of deferoxamine therapy on glucose homeostasis and insulin secretion in individuals with NIDDM and elevated serum ferritin. Diabetes. 1993 Apr;42(4):544–549. doi: 10.2337/diab.42.4.544. [DOI] [PubMed] [Google Scholar]
  43. Rimm E. B., Manson J. E., Stampfer M. J., Colditz G. A., Willett W. C., Rosner B., Hennekens C. H., Speizer F. E. Oral contraceptive use and the risk of type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women. Diabetologia. 1992 Oct;35(10):967–972. doi: 10.1007/BF00401427. [DOI] [PubMed] [Google Scholar]
  44. Seigler D. E., Olsson G. M., Skyler J. S. Morning versus bedtime isophane insulin in type 2 (non-insulin dependent) diabetes mellitus. Diabet Med. 1992 Nov;9(9):826–833. doi: 10.1111/j.1464-5491.1992.tb01901.x. [DOI] [PubMed] [Google Scholar]
  45. Soneru I. L., Agrawal L., Murphy J. C., Lawrence A. M., Abraira C. Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure. Diabetes Care. 1993 Jun;16(6):896–901. doi: 10.2337/diacare.16.6.896. [DOI] [PubMed] [Google Scholar]
  46. Stewart M. W., Laker M. F., Alberti K. G. Effects of self monitoring of triglyceride concentrations in non-insulin dependent diabetes. BMJ. 1993 Feb 20;306(6876):493–493. doi: 10.1136/bmj.306.6876.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Stridsberg M., Berne C., Sandler S., Wilander E., Oberg K. Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule. Diabetologia. 1993 Sep;36(9):843–849. doi: 10.1007/BF00400360. [DOI] [PubMed] [Google Scholar]
  48. Taylor S. I. Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes. 1992 Nov;41(11):1473–1490. doi: 10.2337/diab.41.11.1473. [DOI] [PubMed] [Google Scholar]
  49. Thorsby E., Rønningen K. S. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1993 May;36(5):371–377. doi: 10.1007/BF00402270. [DOI] [PubMed] [Google Scholar]
  50. Vora J. P., Burch A., Peters J. R., Owens D. R. Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care. 1992 Nov;15(11):1484–1493. doi: 10.2337/diacare.15.11.1484. [DOI] [PubMed] [Google Scholar]
  51. Walker M., Agius L., Orskov H., Alberti K. G. Peripheral and hepatic insulin sensitivity in non-insulin-dependent diabetes mellitus: effect of nonesterified fatty acids. Metabolism. 1993 May;42(5):601–608. doi: 10.1016/0026-0495(93)90219-e. [DOI] [PubMed] [Google Scholar]
  52. Wells A. M., Sutcliffe I. C., Johnson A. B., Taylor R. Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Evidence for an abnormality specific to glucose metabolism. Diabetes. 1993 Apr;42(4):583–589. doi: 10.2337/diab.42.4.583. [DOI] [PubMed] [Google Scholar]
  53. Yki-Järvinen H., Kauppila M., Kujansuu E., Lahti J., Marjanen T., Niskanen L., Rajala S., Ryysy L., Salo S., Seppälä P. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1992 Nov 12;327(20):1426–1433. doi: 10.1056/NEJM199211123272005. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES